European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
Union procedure on the preparation, conduct and reporting of EU pharmacovigilance inspections
The team of the European Case Reports Journal in Internal Medicine, EJCRIM is in process of preparing the Book of Abstracts from the 22nd European Congress of Internal Medicine (Istanbul, 6–9 March).
The abstract book will be published on the EJCRIM website in the coming weeks!
If you want to be notified when the book will be online, sign up to the EJCRIM free alert service here.
HMPC: overview of assessment work - priority list
List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Committee for Herbal Medicinal Products (HMPC): 29-31 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 29 January 2024 to 31 January 2024
Human medicines European public assessment report (EPAR): Ximluci, ranibizumab, Date of authorisation: 09/11/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Clopidogrel ratiopharm, clopidogrel, Date of authorisation: 18/02/2015, Revision: 15, Status: Authorised